CK3-61825-93827
5 vaccinations
7 coded responses
44 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 077 / NJ
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-05
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-02
-
2021-02-09
Survey response — day 28, dose 2MedDRA: Headache — Feeling: GoodFree text: More frequent headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-11-16
Dose 3 — Pfizer-BioNTech
- 2022-01-12
-
2022-05-06
Dose 4 — Pfizer-BioNTech
- 2022-05-06
-
2022-05-07
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-08
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-09
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Tender axillary lymphadenopathy on injection sideMedDRA releases: 2024-11 · check-in free text available
- 2022-05-10
- 2022-05-11
- 2022-05-12
- 2022-05-13
- 2022-05-20
- 2022-05-27
-
2022-06-03
Survey response — day 28, dose 4MedDRA: Headache, Throat irritation — Feeling: GoodFree text: Mild headache and scratchy throat.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-14
-
2022-06-17
Survey response — day 42, dose 4MedDRA: Headache, Throat irritation — Feeling: FairFree text: Intermittent scratchy throat and headaches x 2 days, but not persistentMedDRA releases: 2024-11 · check-in free text available
- 2022-08-05
-
2022-10-07
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-13
-
2022-10-14
Survey response — day 7, dose 5MedDRA: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus — Feeling: GoodFree text: None today but one week out. Had significant induration, followed by redness and itching at the injection site from 10/8-10-11. Also tenderness to palpating, but not unprovoked pain, from 10/8-10/10MedDRA releases: 2024-11 · check-in free text available
- 2022-10-21
- 2022-10-28
- 2022-11-04
-
2022-11-11
Survey response — day 35, dose 5MedDRA: Headache — Feeling: FairFree text: Headache today.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-18
Survey response — day 42, dose 5MedDRA: Nasal congestion — Feeling: GoodFree text: Very mild nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2023-01-06
- 2023-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-11-16 | Pfizer-BioNTech | No |
| 4 | 2022-05-06 | Pfizer-BioNTech | No |
| 5 | 2022-10-07 | Pfizer-BioNTech | Flu |
Free text
Release 3 — day 28, dose 2
Symptoms: More frequent headaches
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Tender axillary lymphadenopathy on injection side
Release 11 — day 28, dose 4
Symptoms: Mild headache and scratchy throat.
Release 12 — day 42, dose 4
Symptoms: Intermittent scratchy throat and headaches x 2 days, but not persistent
Release 12 — day 7, dose 5
Systemic reaction (other): None today but one week out. Had significant induration, followed by redness and itching at the injection site from 10/8-10-11. Also tenderness to palpating, but not unprovoked pain, from 10/8-10/10
Release 12 — day 35, dose 5
Symptoms: Headache today.
Release 12 — day 42, dose 5
Symptoms: Very mild nasal congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site induration | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Injection site pruritus | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release